Global Neurodiagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 7.28 Billion |
 Market Size (Forecast Year) |
USD 12.79 Billion |
 CAGR |
% |
| Major Markets Players |
全球神经诊断市场，按产品（诊断成像系统、临床诊断仪器、试剂和消耗品）、病症（神经退行性疾病、中风、癫痫、头痛症、睡眠障碍、神经成像技术、体外诊断、神经信息学）、最终用户（医院和外科中心、诊断实验室和成像中心、神经病学中心、门诊护理中心、研究实验室和学术机构）划分——行业趋势和预测到 2029 年。
神经诊断市场分析和规模
根据全球疾病负担/卫生指标与评估研究所的数据，神经系统疾病是2016年全球伤残调整生命年（DALY）（约2.76亿）和死亡（约900万人）的主要原因。此外，世界卫生组织（WHO）预测，到2030年，患有神经系统疾病的人数将从2015年的9500万人增加到1.03亿人。
Data Bridge Market Research 分析，神经诊断市场在 2021 年为 72.8 亿美元，预计到 2029 年将达到 127.9 亿美元，在 2022 年至 2029 年的预测期内的复合年增长率为 7.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
神经诊断市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（诊断成像系统、临床诊断仪器、试剂和耗材）、病症（神经退行性疾病、中风、癫痫、头痛症、睡眠障碍、神经成像技术、体外诊断、神经信息学）、最终用户（医院和外科中心、诊断实验室和成像中心、神经病学中心、门诊护理中心、研究实验室和学术机构） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare GmbH (Germany), Canon Inc. (Japan), Lifelines Neuro (U.S.), Natus Medical Incorporated. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co. LTD. (Russia), Advanced Brain Monitoring, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Germany), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), FONAR Corp. (U.S.), Fujirebio (Japan), DRG INSTRUMENTS GMBH (Germany), Tecan Trading AG (Switzerland), Agilent Technologies, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Neurodiagnostic tests are typically administered to patients suffering from central nervous system disorders (brain and the spinal cord). These tests monitor and record the electrical activity of the brain, spinal cord, and peripheral nerves to ensure that the disease is diagnosed as soon as possible and as accurately as possible. To provide more detailed diagnostic information, specialized imaging procedures can aid in visualizing changes in brain activity or the amounts of a specific brain chemical.
Global Neurodiagnostics Market Dynamics
Drivers
- Increasing prevalence of neurodegenerative diseases
The global burden of neurological and neurodegenerative diseases has increased demand for effective disease diagnosis. According to the World Health Organization, neurological disorders account for 12% of all deaths worldwide. Furthermore, it is estimated that 276 million people worldwide suffer from various disorders such as Alzheimer's, strokes, epilepsy, migraine, and among others. The market for neurodiagnostics will be promising and lucrative growth in the coming years, due to the increasing incidence of neurological disorders and the growing need for early diagnosis
- Technological advancements in the neurodiagnostics
Diagnostic imaging manufacturers are investing in incorporating technological advancements into their modalities that can help accurately diagnose neurological disorders. For instance, Medtronic PLC's Stealth Station S8 Neurosurgery System provides clear visualization and surgical navigation of every segment of the spine. It includes technologies such as 3D cameras, electromagnetic sensors, tracking algorithms, data processing software, and much more. Such technologies simplify the entire diagnostic process, propelling the global neurodiagnostics market.
Opportunities
- Rising prevalence of epilepsy
According to the World Health Organization, an estimated five million people worldwide are diagnosed with epilepsy each year. Epilepsy is expected to affect 50 out of every 100,000 people in high-income countries yearly. In low- and middle-income countries, this rate can reach 140 per 100,000. This is most likely due to an increased risk of recurring neurological illnesses, a higher frequency of traffic accidents and birth-related traumas, differences in healthcare technology, and the availability of preventative health programmes and affordable care. These are the factors which propel the growth of the market.
Restraints/Challenges
- High cost of diagnosis and imaging technologies
Adoption of imaging technologies necessitates significant investment, and the high cost of these technologies limits their use, particularly in developing and low-income countries' healthcare facilities. An ultrasound machine can range in price from USD 20,000 to USD 200,000, with some machines costing even more.
On the other hand, A PET scanner costs approximately USD 2 million, while an MRI scanner costs approximately USD 1 million. These amounts are regarded as prohibitively expensive, limiting adoption and market growth.
This neurodiagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neurodiagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Neurodiagnostics Market
The COVID-19 pandemic placed a tremendous strain on the entire healthcare system. A lack of medical resources was impairing the COVID-19 outbreak, and more people became infected daily. As a result, healthcare facilities began to invest in acquiring respiratory support devices such as life support machines, oxygen generators, ventilators, PPE kits, masks, and gloves, among others. As a result, demand for the neurodiagnostics market fell significantly, negatively impacting the global neurodiagnostics market. Furthermore, the manufacturing of such devices was hampered by lockdown and social distancing protocols, resulting in significant losses for the manufacturers.
Recent developments
- In May 2021, Sense Neuro Diagnostics, a medical tech startup based in the United States, announced a strategic collaboration with Inflect Health, a venture capital health, to develop devices to improve the outcomes of stroke and brain injury patients.
- 2021年12月，总部位于美国的医疗设备制造商Rhythmlink International LLC宣布收购医疗设备制造商Chalgren Enterprises，以扩大其大脑和神经系统监测产品组合。
全球神经诊断市场范围
神经诊断市场根据产品、状况和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 诊断成像系统
- 超声波成像系统
- 脑电图系统
- MEG 设备
- MRI 系统
- 血管造影系统
- PET 扫描仪
- CT 扫描仪
- 肌电图设备
- 其他诊断成像系统
- 临床诊断仪器
- 仪器
- NGS 仪器
- 桑格测序仪
- 其他临床诊断仪器
- 试剂和耗材
- 培养基和血清
- 探针
- 抗体
- 酶、蛋白质和肽
- 缓冲区
- 溶剂
- 其他试剂和耗材
健康）状况
- 神经退行性疾病
- 头痛症
- 中风
- 睡眠障碍
- 癫痫
- 神经影像技术
- 计算机断层扫描 (CT)
- 磁共振成像（MRI）
- 核医学成像（PET、SPECT）
- 近红外光谱成像 (NIRS)
- 脑电图 (EEG)
- 脑磁图 (MEG)
- 基于体素的形态测量 (VBM)
- 体外诊断
- 神经信息学
终端用户
- 医院和外科中心
- 门诊护理设置
- 诊断实验室和影像中心
- 神经病学中心
- 学术及研究机构
神经诊断市场区域分析/见解
对神经诊断市场进行了分析，并按国家、产品、条件和最终用户提供了市场规模洞察和趋势，如上所述。
神经诊断市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于医疗设施完善、先进工具易于获得以及制造公司数量众多，北美在神经诊断市场占据主导地位。
由于神经系统疾病和神经退行性疾病，预计亚太地区在 2022 年至 2029 年的预测期内将以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
神经诊断市场还为您提供每个国家/地区资本设备医疗支出增长、神经诊断市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对神经诊断市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。
竞争格局和神经诊断市场份额分析
神经诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对神经诊断市场的关注有关。
神经诊断市场的一些主要参与者包括：
- 通用电气（美国）
- Koninklijke Philips NV（荷兰）
- 西门子医疗有限公司（德国）
- 佳能公司（日本）
- 生命线神经科（美国）
- 内特斯医疗公司。 （我们）
- F. Hoffmann-La Roche Ltd（瑞士）
- 富士胶片控股株式会社（日本）
- Mitsar 有限公司（俄罗斯）
- Advanced Brain Monitoring, Inc.（美国）
- 赛默飞世尔科技公司（美国）
- Bio-Rad Laboratories, Inc.（美国）
- QIAGEN（德国）
- 日本光电株式会社（日本）
- ANT Neuro（荷兰）
- FONAR 公司（美国）
- Fujirebio（日本）
- DRG INSTRUMENTS GMBH（德国）
- Tecan Trading AG（瑞士）
- 安捷伦科技公司（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
